Welcome to our dedicated page for QT Imaging Holdings news (Ticker: qti), a resource for investors and traders seeking the latest updates and insights on QT Imaging Holdings stock.
QT Imaging Holdings (QTI) provides cutting-edge diagnostic imaging solutions for healthcare and industrial applications. This page serves as a comprehensive resource for official company announcements, financial updates, and technology developments.
Access timely updates on product innovations, regulatory milestones, and strategic partnerships. Investors and industry professionals will find curated press releases covering earnings reports, research breakthroughs, and operational expansions.
All content is verified for accuracy and relevance, offering a centralized hub for tracking QTI's advancements in medical imaging technology. Key focus areas include high-resolution systems, quality control processes, and cross-industry applications of imaging solutions.
Bookmark this page for direct access to primary source materials about QTI's market position and technological leadership. Check regularly for updates reflecting the company's commitment to imaging innovation and operational excellence.
QT Imaging Holdings (NASDAQ: QTI) reported financial results for Q2 2024:
- Generated $1.7 million in scanner sales revenue with a 51% gross margin
- Net loss of $1.2 million, including $2.1 million non-cash income from fair value changes
- Non-GAAP Adjusted EBITDA of $(2.1) million
Key developments:
- Signed U.S. exclusive distribution agreement with NXC Imaging
- Partnered with University of Oklahoma and OU Health Stephenson Cancer Center
- Delivered four Breast Acoustic CT scanners, expanding to five commercial locations
- Published study showing accurate visualization of breast tissue using QT technology
Outlook: Expects similar revenue pace in H2 2024 with higher gross margins
QT Imaging Holdings (NASDAQ:QTI) has announced a partnership with PerfeQTion Imaging Center in Haverford, Pennsylvania, shipping their Breast Acoustic CT™ Scanner to the facility. Founded by Dr. Jennifer Simmons, PerfeQTion Imaging™ Center offers screening, diagnostic exams, and monitoring services. The QTI technology provides a safe, painless, and accurate alternative for breast imaging, without the use of radiation.
Dr. Simmons believes this technology will revolutionize breast cancer screening, especially for young and high-risk women who are more susceptible to radiation damage. QTI's CEO, Dr. Raluca Dinu, emphasized that their technology is expanding medical imaging opportunities beyond traditional settings, supporting direct-to-provider approaches to lower healthcare costs and increase access.
QT Imaging Holdings (NASDAQ:QTI) has partnered with the University of Oklahoma and OU Health Stephenson Cancer Center to advance medical imaging research. The collaboration aims to enhance cancer detection and treatment using QT Imaging's Breast Acoustic CT™ technology. This pioneering imaging system offers quantitative imaging predictive markers to improve diagnostic precision and consistency. The University of Oklahoma's imaging center, a National Cancer Institute-designated facility, will leverage this technology in its innovative research initiatives. Furthermore, the collaboration will explore AI and ML-based algorithms to streamline clinical workflows and extract more insights from the imaging data. Dr. Javier Jo, Director at OU, and Dr. Bilal Malik, QTI’s Chief Science Officer, both emphasize the potential of this partnership to transform cancer care and develop new technological avenues in breast cancer research.
QT Imaging Holdings, Inc. (NASDAQ: QTI) reported revenue of $1.4 million in Q1 2024, with a 56% gross margin. The company streamlined operations through a strategic sales partnership in the USA and completed a merger with GigCapital5. A blinded screening trial confirmed the efficacy of QTI technology. Financially, while revenue increased significantly, the net loss was $4.3 million, including non-cash income related to the merger. The company also announced key partnerships and leadership updates, aiming for continued growth in 2024.
QT Imaging Holdings, Inc. (NASDAQ:QTI) partners with The Vincere Cancer Center in Scottsdale, AZ, renowned for cancer prevention, early detection, and innovative cancer services. The center's founders, Dr. Shukla and Dr. Prichard, focus on superior cancer care with precision technology. The partnership aims to redefine standards of care in breast cancer detection, offering accessible and accurate screening solutions.
FAQ
What is the current stock price of QT Imaging Holdings (qti)?
What is the market cap of QT Imaging Holdings (qti)?
